Morning Overview on MSN

A cancer drug just became the first FDA-cleared treatment for a common breast-cancer subtype

Patients with the most common molecular subtype of advanced breast cancer now have a targeted drug approved specifically for ...

Atossa Therapeutics Announces Presentation of Mechanism-Driven (Z)-Endoxifen Data in McCune-Albright Syndrome at AACR Special Conference on Rare Cancers

Atossa Therapeutics, Inc. (NASDAQ: ATOS) ("Atossa" or the "Company"), a clinical-stage biopharmaceutical company developing novel therapies in oncology and other areas of significant unmet clinical ...

'Seek happiness': How Dale Merriman is 'thriving' with stage 4 cancer

Facing a stage 4 cancer diagnosis would be enough to send anyone into the depths of despair. But Dale Merriman is not only ...
Medical Dialogues

New research shows how AI may help avoid unnecessary chemotherapy for breast cancer patients

Research led by RCSI University of Medicine and Health Sciences and University College Dublin (UCD) has identified immune ...
The Lancet

Breast cancer incidence, by stage at diagnosis, and mortality in 21 European countries in the era of mammography screening: an international population-based study

vDepartment of Epidemiology, North Region Cancer Registry of Portugal (RORENO), Portuguese Oncology Institute of Porto (IPO Porto), Porto, Portugal wGroup of Epidemiology, Outcomes, Economics and ...